Manson Unit, Médecins Sans Frontières, London, UK.
Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.
Trials. 2021 Dec 4;22(1):881. doi: 10.1186/s13063-021-05850-0.
Addressing the global burden of multidrug-resistant tuberculosis (MDR-TB) requires identification of shorter, less toxic treatment regimens. Médecins Sans Frontières (MSF) is currently conducting a phase II/III randomised controlled clinical trial, to find more effective, shorter and tolerable treatments for people with MDR-TB. Recruitment to the trial in Uzbekistan has been slower than expected; we aimed to study patient and health worker experiences of the trial, examining potential factors perceived to impede and facilitate trial recruitment, as well as general perceptions of clinical research in this context.
We conducted a qualitative study using maximum variation, purposive sampling of participants. We carried out in-depth interviews (IDIs) and focus group discussions (FGDs) guided by semi-structured topic guides. In December 2019 and January 2020, 26 interviews were conducted with patients, Ministry of Health (MoH) and MSF staff and trial health workers, to explore challenges and barriers to patient recruitment as well as perceptions of the trial and research in general. Preliminary findings from the interviews informed three subsequent focus group discussions held with patients, nurses and counsellors. Focus groups adopted a person-centred design, brainstorming potential solutions to problems and barriers. Interviews and FGDs were audio recorded, translated and transcribed verbatim. Thematic analysis, drawing on constant comparison, was used to analyse the data.
Health system contexts may compete with new approaches especially when legislative health regulations or policy around treatment is ingrained in staff beliefs, perceptions and practice, which can undermine clinical trial recruitment. Trust plays a significant role in how patients engage with the trial. Decision-making processes are dynamic and associated with relationship to diagnosis, assimilation of information, previous knowledge or experience and influence of peers and close relations.
This qualitative analysis highlights ways in which insights developed together with patients and healthcare workers might inform approaches towards improved recruitment into trials, with the overall objective of delivering evidence for better treatments.
为了应对全球耐多药结核病(MDR-TB)的负担,需要寻找更短、毒性更小的治疗方案。无国界医生组织(MSF)目前正在进行一项 II/III 期随机对照临床试验,以寻找更有效、更短、更耐受的 MDR-TB 治疗方法。乌兹别克斯坦的试验招募速度比预期的要慢;我们旨在研究患者和卫生工作者对试验的体验,检查阻碍和促进试验招募的潜在因素,以及在这种情况下对临床研究的一般看法。
我们采用最大变异、有目的地选择参与者进行定性研究。我们使用半结构化主题指南进行深入访谈(IDIs)和焦点小组讨论(FGDs)。2019 年 12 月和 2020 年 1 月,我们与患者、卫生部(MoH)和 MSF 工作人员以及试验卫生工作者进行了 26 次访谈,以探讨患者招募的挑战和障碍,以及对试验和一般研究的看法。访谈的初步结果为随后与患者、护士和顾问进行的三次焦点小组讨论提供了信息。焦点小组采用以人为本的设计,集思广益,提出解决问题和障碍的方案。访谈和 FGDs 都进行了录音、翻译和逐字记录。采用恒比比较的主题分析方法对数据进行分析。
卫生系统环境可能与新方法竞争,特别是当治疗的立法卫生法规或政策根深蒂固于员工的信念、观念和实践中时,这可能会破坏临床试验的招募。信任在患者参与试验的方式中起着重要作用。决策过程是动态的,与诊断、信息吸收、以前的知识或经验以及同伴和密切关系的影响有关。
这项定性分析强调了与患者和医疗保健工作者共同开发的见解如何为改善试验招募提供信息的方法,总体目标是提供更好治疗方法的证据。